Viewing Study NCT00310648



Ignite Creation Date: 2024-05-05 @ 4:46 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00310648
Status: COMPLETED
Last Update Posted: 2006-09-14
First Post: 2006-04-03

Brief Title: Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects 60 Years
Sponsor: Novartis
Organization: Novartis

Study Overview

Official Title: Part 1Phase I Open-Label Single-Center to Evaluate the Safety of a Commercially Available Adjuvanted Influenza Vaccine When Administered to Elderly Subjects Part 2 A Phase III Randomized Controlled Observer-Blind Single-Center Study to Evaluate the Immunogenicity and Safety of a Commercially Available Influenza Vaccine and a Conventional Commercially Available Influenza Vaccine When Administered to Elderly Subjects
Status: COMPLETED
Status Verified Date: 2006-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Clinical Trial in Two parts

Part 1 Phase I Open-Label Single-Center Study to Evaluate the Safety of an adjuvanted Influenza Vaccine When Administered to Elderly Subjects

Part 2 A Phase III Randomized Controlled Observer-blind Single-Center Study to Evaluate the Immunogenicity and Safety of an adjuvanted and a conventional Influenza Vaccine When Administered to Elderly Subjects
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
Part 2 200511-III None None None
Part 1 200511-I None None None